The stock of ABUS gained significantly in the pre-market after the company was upgraded from hold to buy by the analyst firm Jefferies. ABUS values
Arbutus Biopharma Corp. (ABUS), a biopharmaceutical company, has gained an increase of 2.39% in aftermarket trading session. Consequently, ABUS is trading at $4.72 at the time of
The stock of Arbutus Biopharma Corporation (ABUS) was trading at $2.97 in pre-market trading hours on Wednesday, up 1.37%. Arbutus stock lost -0.68% last session
As the U.S. reached 300,000 deaths connected with Covid-19, the first shots were given. The nurse in New York City was first vaccinated against COVID-19.
China Automotive Systems Inc. (CAAS) stock soared 2.38% to $10.75 in the pre-market trading after reporting that it shipped approximately 120,000 units from its portfolio
FuelCell Energy Inc. (FCEL) stock soared 4.75% to $10.15 in the pre-market trading. The most recent rating by JP Morgan, on November 19, 2020, is
CBAK Energy Technology Inc. (CBAT) stock soared 51.22% to $9.3 in pre-market trading. Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) shares are trading
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.